Cargando…

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?

Detalles Bibliográficos
Autor principal:	Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791853/ https://www.ncbi.nlm.nih.gov/pubmed/26908580 http://dx.doi.org/10.1128/mBio.02228-15

Ejemplares similares

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: Fedson, David S., et al.
Publicado: (2016)

Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
por: Fedson, David S., et al.
Publicado: (2015)

Ebola, fear and preparedness
por: wiwanitkit, viroj
Publicado: (2014)

Psychological Manifestation in Dengue: Did it Really exist?
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

Knowledge regarding Ebola Hemorrhagic Fever among private dental practitioners
por: Wiwanitkit, Viroj
Publicado: (2015)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
por: Gupta, Nitesh, et al.
Publicado: (2020)

To do or not to do: Angiotensin converting enzyme inhibitors/angiotensin receptor blocker in COVID-19 elderly patients
por: Vura, Naga Venkata Rama Krishna, et al.
Publicado: (2021)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Re: Is there a difference in the effect between the angiotensin‐converting enzyme inhibitor and angiotensin‐receptor blocker on the COVID‐19?
por: Liu, Xiao, et al.
Publicado: (2020)

Angiotensin-converting enzyme G2350A gene polymorphisms and hypertension among patients with intracerebral hemorrhage
por: Joob, Beuy, et al.
Publicado: (2019)

Are surveillance response systems enough to effectively combat and contain the Ebola outbreak?
por: Wiwanitkit, Viroj, et al.
Publicado: (2015)

Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
por: Mateti, Uday Venkat, et al.
Publicado: (2014)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

Hyperkalemia from preoperative non-steroidal anti-inflammatory drugs and angiotensin II receptor blockers in patients with nephropathy
por: Song, Ho Kyung, et al.
Publicado: (2011)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Daoud, Ahmed, et al.
Publicado: (2021)

Ebola virus disease 2014: Induction of abnormal cardiac rhythm?
por: Wiwaiiitkit, Viroj
Publicado: (2016)

Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view
por: Shirazi, Farshad M., et al.
Publicado: (2020)

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.)
por: Ekiz, Timur, et al.
Publicado: (2020)

Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis
por: Lee, Seul-Gee, et al.
Publicado: (2019)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
por: Eroğlu, İmdat, et al.
Publicado: (2020)

An epidemiological study exploring a possible impact of treatment with ACE inhibitors or angiotensin receptor blockers on ACE2 plasma concentrations
por: Wild, Philipp S., et al.
Publicado: (2020)

Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration
por: Lee, Hyesung, et al.
Publicado: (2019)

Correspondence on Leptin Receptor Q223R Gene Polymorphism and Breast Cancer
por: Kebayoon, Amnuay, et al.
Publicado: (2022)

Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?
por: Jang, Byoung Kuk
Publicado: (2022)

Vitamin D receptor gene BsmI polymorphism with type 2 diabetes mellitus
por: Joob, Beuy, et al.
Publicado: (2020)

Cytokine Receptor Allele Frequency, Immunogenicity, and Efficacy of New COVID-19 Vaccine in Different Setting
por: Joob, Beuy, et al.
Publicado: (2023)

Delivery of nutraceuticals using nanotechnology
por: Wiwanitkit, Viroj
Publicado: (2012)

Use of triptans for the control of headache in bacterial meningitis
por: Wiwanitkit, Viroj
Publicado: (2014)

Breast cancer, diabetes mellitus and usefulness of immunonutrition
por: Wiwanitkit, Viroj
Publicado: (2012)

Preconception genetic carrier screening: use and problems
por: Wiwanitkit, Viroj
Publicado: (2017)

Use of Indian (Ayurveda) style alternative medicine in Thailand
por: Wiwanitkit, Viroj
Publicado: (2010)

Inappropriate concomitant use of amlodipine and simvastatin: A report on its incidence in a primary care unit
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Vertebroplasty for osteoporotic vertebral fractures: Additional concern on its usefulness
por: Wiwanitkit, Viroj
Publicado: (2009)

The concern on clinical use of recombinant human bone morphogenetic protein-2
por: Wiwanitkit, Viroj
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_n53r3flmprksm4escf0q40fj2m